Yandrapalli S, Cooper HA, Malekan R. Successful coronary artery bypass operation in a SARS‐COV‐2 infected patient with acute coronary syndrome. J Card Surg. 2020;1--3. 10.1111/jocs.14784

1. INTRODUCTION {#jocs14784-sec-0010}
===============

Coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an ongoing pandemic.[^1^](#jocs14784-bib-0001){ref-type="ref"} Earlier reports have demonstrated complicated Postoperative courses and high fatality rates in patients undergoing emergent cardiothoracic surgery and diagnosed postoperatively with COVID‐19.[^2^](#jocs14784-bib-0002){ref-type="ref"}, [^3^](#jocs14784-bib-0003){ref-type="ref"}, [^4^](#jocs14784-bib-0004){ref-type="ref"}, [^5^](#jocs14784-bib-0005){ref-type="ref"} We present the first report of a coronary artery bypass grafting operation (CABG) with a successful outcome in a patient with SARS‐CoV‐2 infection.

2. CASE PRESENTATION {#jocs14784-sec-0020}
====================

A 67‐year‐old female with a history of obesity, gastric acid reflux disease, and hiatal hernia repair presented with persistent chest pain of 1‐day duration. Her husband had weakness and fatigue of 1‐week duration. Laboratory testing is presented in Figure [1](#jocs14784-fig-0001){ref-type="fig"}. Given exposure to her husband who had nonspecific symptoms, nasal swab testing for the SARS‐CoV‐2 was done which returned positive. She did not have respiratory symptoms, hypoxia, or fevers suggestive of COVID‐19 pneumonia. Chest radiography showed clear lung fields (Figure [1](#jocs14784-fig-0001){ref-type="fig"}, panel A). She was admitted for a non‐ST elevation myocardial infarction. Cardiac catheterization revealed severe three‐vessel coronary artery disease (CAD), a culprit lesion in a large branching first diagonal with complete occlusion and grade 2 left to left collaterals; diffuse, severe, proximal and mid‐left anterior descending artery CAD, and severe proximal right coronary artery CAD. There was severe distal left circumflex and left posterior descending artery CAD. Echocardiography revealed normal ventricular function without any wall motion abnormalities.

![Laboratory and Radiographic findings. Panel A, Chest radiograph on presentation showing clear lung fields. Panel B, A chest computed tomographic image in the axial plane demonstrates clear lung parenchyma. Panel C, Postoperative day 3 radiograph showing bibasilar atelectasis and bilateral pleural effusions. Panel D, Chest radiograph before discharge demonstrated improved atelectasis and pleural effusions](JOCS-9999-na-g001){#jocs14784-fig-0001}

In the setting of continued symptoms from the acute coronary syndrome and multivessel CAD, cardiac surgical consultation was requested. Laboratory testing to identify inflammatory markers elevations associated with COVID‐19 returned normal; Figure [1](#jocs14784-fig-0001){ref-type="fig"} **.** Computed tomographic (CT) chest imaging confirmed clear lung fields without pulmonary parenchymal pathology (Figure [1](#jocs14784-fig-0001){ref-type="fig"}, panel B). We explained to the patient that COVID‐19 might carry substantial postoperative risks. Infectious diseases and hematology consultations were requested to quantify COVID‐19 related pneumonia and pulmonary coagulopathic risks. After ruling out active COVID‐19 infection and deciding on a possibly low COVID‐19 flare risk with the above testing and consultations, we decided to proceed with CABG surgery. The society of thoracic surgery (STS) score estimated a 1.5% risk of postoperative mortality.

Following uneventful induction of general anesthesia, aorta‐bicaval cannulation was utilized for cardiopulmonary bypass. Myocardium was protected with cold blood cardioplegia. Coronary revascularization was performed with an in situ left internal mammary arterial graft to the left anterior descending artery, saphenous venous graft to the first diagonal, and saphenous venous graft to the left posterior descending artery. The patient was weaned from cardiopulmonary bypass without difficulty and transferred to the intensive care unit (ICU). She was extubated within 4 hours of ICU admission and transitioned to nasal cannula oxygen at 2 L/min. Acute blood loss anemia was managed with transfusion. Postoperative day 1 chest radiograph showed atelectasis which was managed with incentive spirometry and pain control. Subsequent radiographs showed the development of bilateral small pleural effusions (Figure [1](#jocs14784-fig-0001){ref-type="fig"}, panel C), accompanied by the requirement for increase in nasal oxygen support to 5 L/min. The effusions were successfully treated with furosemide. The patient was then transferred to the step‐down unit on postoperative day 4. She was afebrile during this period with no significant laboratory abnormalities. Respiratory status continued to improve, with improvement in chest radiography findings and nasal oxygen support was gradually weaned off (Figure [1](#jocs14784-fig-0001){ref-type="fig"}, panel D). The patient was discharged home on postoperative day 6.

3. DISCUSSION {#jocs14784-sec-0030}
=============

We present a case of a successful CABG surgery in a patient with asymptomatic SARS‐CoV‐2 infection presenting with acute coronary syndrome and with multi‐vessel severe CAD requiring urgent surgery. We thoroughly evaluated the patient to identify active COVID‐19 infection by assessing for common inflammatory markers and CT findings associated with COVID‐19. After confirming the absence of subclinical COVID‐19 and estimating a low COVID‐19 flare risk with inflammatory marker testing and specialist consultations, we proceeded with the CABG operation with a favorable outcome and without postoperative COVID‐19 manifestations.

To the best of our knowledge, there are no published reports of CABG operation in patients with pre‐operatively confirmed SARS‐CoV‐2 infection. In a report of postoperatively diagnosed COVID‐19 after CABG for an acute coronary syndrome, the patient succumbed to severe pneumonia.[^2^](#jocs14784-bib-0002){ref-type="ref"} In accordance with the United Kingdom National Health Service recommendations, the patient was not initially tested for the SARS‐CoV‐2 at presentation (15 days before surgery) as he did not have COVID‐19 symptoms and had normal inflammatory markers.[^2^](#jocs14784-bib-0002){ref-type="ref"} A chest CT scan at presentation showed mild chronic obstructive pulmonary disease. The patient developed pneumonia on postoperative day 1 with severe hypoxia and fever. Chest radiography showed bilateral consolidation and bronchial‐alveolar lavage was positive for SARS‐CoV‐2. The authors recognized that undiagnosed or potentially concomitant COVID‐19 infection might precipitate a catastrophic pathologic response refractory to standard treatments after cardiac surgery which might pose a challenge to clinicians.[^2^](#jocs14784-bib-0002){ref-type="ref"} In a case series if eleven patients with COVID‐19 infection diagnosed after lung cancer surgery, three patients expired in the immediate postoperative period.[^4^](#jocs14784-bib-0004){ref-type="ref"} In two other reports of emergency thoracic surgery (embolectomy for pulmonary embolism and acute type A aortic dissection repair) and postoperatively diagnosed COVID‐19, the patients had a complicated postoperative course and eventually died from multiorgan dysfunction.[^3^](#jocs14784-bib-0003){ref-type="ref"}, [^5^](#jocs14784-bib-0005){ref-type="ref"} A review of a preoperative CT chest in one of these patients showed signs consistent with COVID‐19 lung lesions.[^3^](#jocs14784-bib-0003){ref-type="ref"}

The key takeaway points from our case presentation are: (a) Routine testing for the SARS‐CoV‐2 in all patients who require cardiac surgery to identify asymptomatic/subclinical infection. (b) In asymptomatic SARS‐CoV‐2 infection, assessing for subclinical active infection (with inflammatory markers and CT chest) helps to identify patients at higher risk of developing postoperative complications. This is especially important for patients requiring cardiopulmonary bypass as subclinical pneumonia can result in severe hypoxia and complicate weaning from cardiopulmonary bypass. (c) Careful monitoring of all SARS‐COV‐2 positive patients postoperatively for development of COVID‐19. Nasal swab testing with reverse transcriptase‐polymerase chain reaction to detect the SARS‐CoV‐2 RNA has only 70% sensitivity. Any clinical change to suggest active COVID‐19 in the preoperative or postoperative period should prompt repeat swab testing or chest CT imaging to improve risk stratification. Chest CT screening has a higher sensitivity (98%) than nasal swab for SARS‐CoV‐2 infection as CT findings occur earlier.[^6^](#jocs14784-bib-0006){ref-type="ref"} Post‐intubation bronchoalveolar lavage can be considered.

As we move forward in this pandemic, we need to continue to provide appropriate medical care for patients with asymptomatic or subclinical SARS‐COV‐2 infection who require cardiac surgery. Careful screening strategies, standard guideline recommendations and hospital level protocols are required to identify higher risk patients who are at greater risk of postsurgical morbidity and mortality.
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